Compare ACADIA Pharmaceuticals Inc. (ACAD) vs Applied Materials, Inc. (AMAT) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ACADIA Pharmaceuticals Inc. vs Applied Materials, Inc. — how do they compare? ACADIA Pharmaceuticals Inc. trades at $25.99 (market cap $4.49B), while Applied Materials, Inc. trades at $572 (market cap $440.25B). The key difference: Applied Materials, Inc. is far larger — about 98.1× ACADIA Pharmaceuticals Inc.'s market cap, and Applied Materials, Inc. pays a 0.38% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | AMAT | |
|---|---|---|
Market Cap | $4.49B | $440.25B |
Sector | Health | Technology |
52-Week High | $28.06 | $723.00 |
52-Week Low | $20.06 | $156.25 |
Enterprise Value | $3.69B | $439.28B |
Dividend Yield | — | 0.38% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Applied Materials (AMAT) trades at $570.50, down 3.76% today, amid a bearish technical signal. The stock shows strong fundamentals with consistent earnings beats (Q1 2026 EPS of $2.86 vs. $2.68 expected) and robust profitability (net margin of 29.31%). Recent news highlights CEO Gary Dickerson's bullish outlook on AI-driven semiconductor demand, calling it 'the greatest time in the history of our industry' (CNBC, 2026-05-28).
The outlook remains positive with a consensus price target of $622.57 (9.1% upside), though high valuation ratios (P/E of 52.16) and technical resistance near $573 pose near-term risks. AI infrastructure growth and strong analyst support (76.9% buy ratings) underpin long-term potential, but investors should monitor execution amid competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →About Applied Materials, Inc.
Applied Materials is the world's largest supplier of semiconductor manufacturing equipment, providing materials engineering solutions to help make nearly every chip in the world. The firm's systems are used in nearly every major process step with the exception of lithography. Key tools include those for chemical and physical vapor deposition, etching, chemical mechanical polishing, wafer- and reticle-inspection, critical dimension measurement, and defect-inspection scanning electron microscopes.
Read more on AMAT →
